Published in Arch Klin Exp Ohren Nasen Kehlkopfheilkd on January 01, 1967
[Storage, formation, and metabolism of histamine in the salivary glands and tonsils]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1968) 0.75
Histamine shock. J Physiol (1919) 30.76
A CLINICAL STUDY OF THE ACTION OF 10 COMMONLY USED DRUGS ON CARDIAC OUTPUT, WORK AND SIZE; ON RESPIRATION, ON METABOLIC RATE AND ON THE ELECTROCARDIOGRAM. J Clin Invest (1937) 29.26
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (1929) 23.79
Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide). Lancet (1962) 8.89
On the action of adrenaline on the blood vessels in human skeletal muscle. J Physiol (1946) 7.14
Pharmacology of indole-alkylamines. Pharmacol Rev (1954) 5.46
Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev (1963) 4.54
THE ACTION OF PEPTIDES ON THE ADRENAL MEDULLA. RELEASE OF ADRENALINE BY BRADYKININ AND ANGIOTENSIN. J Physiol (1964) 4.23
On the actions of noradrenaline, adrenaline and isopropyl noradrenaline on the arterial blood pressure, heart rate and muscle blood flow in man. J Physiol (1949) 3.94
Further observations on the effect of adrenaline on the blood flow through human skeletal muscle. J Physiol (1951) 3.79
Active polypeptides derived from plasma proteins. Physiol Rev (1960) 3.27
Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation (1959) 3.27
The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol (1951) 3.21
Angiotensin. Physiol Rev (1961) 2.99
REGULATION OF CORONARY BLOOD FLOW. Physiol Rev (1964) 2.95
THE NATURE OF CIRCULATORY COLLAPSE INDUCED BY SODIUM NITRITE. J Clin Invest (1937) 2.90
Humoral agents and venous tone. Effects of catecholamines, 5-hydroxytryptamine, histamine, and nitritex. Lancet (1962) 2.57
Nervous control of the blood vessels. Physiol Rev (1955) 2.48
A study of the adrenotropic receptors. Am J Physiol (1948) 2.19
THE RENIN-ANGIOTENSIN SYSTEM. Pharmacol Rev (1965) 2.18
Pheochromocytoma and essential hypertensive vascular disease. AMA Arch Intern Med (1950) 2.15
The action of drugs on the cerebral circulation. Pharmacol Rev (1959) 2.10
Serotonin (5-hydroxytryptamine); the last four years. Physiol Rev (1958) 1.89
Bradykinin as a vasodilator in man. J Physiol (1961) 1.83
Serotonin (5-hydroxytryptamine). Physiol Rev (1954) 1.80
Neurophypophysial hormones. Pharmacol Rev (1961) 1.80
Action of nitroglycerin on the coronary circulation in normal and in mild cardiac subjects. Circulation (1959) 1.77
The effect of epinephrine (USP), l-epinephrine, and l-norepinephrine on glomerular filtration rate, renal plasma flow, and the urinary excretion of sodium, potassium, and water in normal man. J Clin Invest (1952) 1.76
The comparative effects of angiotensin and noradrenaline on consecutive vascular sections. Acta Physiol Scand (1961) 1.73
Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache. N Engl J Med (1960) 1.72
The action of 5-hydroxytryptamine on the blood vessels of the human hand and forearm. Br J Pharmacol Chemother (1955) 1.67
Pharmacology of the coronary circulation. Pharmacol Rev (1951) 1.55
The effects of l-epinephrine and l-norepinephrine upon cerebral circulation and metabolism in man. J Clin Invest (1952) 1.44
The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man. J Clin Invest (1950) 1.44
Effects of bradykinin on the systemic and coronary vascular bed of the intact dog. Circ Res (1962) 1.42
Comparison of the actions of adrenaline and noradrenaline on the cardiac output in man. Clin Sci (Lond) (1951) 1.36
Comparison of plethysmograph and thermo-electric needle records of calf blood flow during intravenous adrenaline infusions. J Physiol (1955) 1.33
Effect of histamine on small and large vessel pressures in the dog foreleg. Am J Physiol (1960) 1.28
The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension. Am J Med (1948) 1.25
Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds. Circulation (1962) 1.22
Ergotamine tolerance in patients with migraine. J Am Med Assoc (1955) 1.19
Modification of sympathetic function. Indirectly acting sympathomimetic amines. Pharmacol Rev (1966) 1.17
A serotonin antagonist in the treatment of allergic and allied disorders. Ann Allergy (1961) 1.17
The response of normal retinal blood vessels to angiotensin and noradrenaline. J Physiol (1963) 1.17
[Effect of synthetic hypertensin II on PAH- and inulin clearance, on renal hemodynamics and on diuresis in man]. Klin Wochenschr (1958) 1.16
Release of adenosine from anoxic hearts. Relationship to coronary flow. Circ Res (1966) 1.14
Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine. Br Med Bull (1963) 1.13
The effect of nicotinic acid on the cerebral circulation, with observations on extra-cerebral contamination of cerebral venous blood in the nitrous oxide procedure for cerebral blood flow. Circulation (1950) 1.10
The effect of theophylline with ethylenediamine (aminophylline) on cerebral hemodynamics in the presence of cardiac failure with and without Cheyne-Stokes respiration. J Clin Invest (1952) 1.09
The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure. J Clin Invest (1949) 1.08
[Comparison of the peripheral vascular properties of synthetic hypertensin and various vasoconstrictors]. Arch Int Pharmacodyn Ther (1958) 1.07
A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject. Circulation (1954) 1.06
ADRENERGIC RECEPTORS WITHIN THE CARDIOVASCULAR SYSTEM. Circulation (1963) 1.05
[The elimination of adenosine from the blood under the influence of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido-(5,4-d) pyrimidine and papaverine]. Arzneimittelforschung (1962) 1.05
The effect of theophylline ethylenediamine on the pulmonary circulation. Am Heart J (1958) 1.04
Effect of angiotensin infusion on regional blood flow and regional vascular resistance in the rat. Circ Res (1962) 1.04
EFFECT OF ANGIOTENSIN II ON THE INTACT FOREARM VEINS OF MAN. Circ Res (1963) 1.02
THE EFFECTS OF NITROGLYCERIN ON THE CORONARY BLOOD FLOW AND OXYGEN CONSUMPTION OF THE MYOCARDIUM IN ANESTHETIZED DOGS. Am J Cardiol (1964) 1.01
Weal and flare in human skin produced by histamine and other substances. Nature (1959) 1.00
Effects of various drugs upon cerebral circulation and metabolism of man. J Appl Physiol (1951) 1.00
[On plasmakinins]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1963) 0.99
THE ACTION OF ANGIOTENSIN IN MAN. Clin Sci (1963) 0.98
Coronary vasodilation produced by bradykinin on isolated mammalian heart. Circ Res (1962) 0.97
The effect of theophylline with ethylenediamine (aminophylline) and caffeine on cerebral hemodynamics and cerebrospinal fluid pressure in patients with hypertensive headaches. Am J Med Sci (1952) 0.96
Pharmacology of renin and hypertension. Pharmacol Rev (1956) 0.96
Intercellular cement and capillary permeability. Physiol Rev (1947) 0.94
[Studies on the effect of synthetic hypertensin II on blood pressure, respiration and blood circulation of extremities in man]. Klin Wochenschr (1958) 0.93
[Competitive inhibition of adenosine aminase as a possible cause of the coronary dilating effects of a pyrimidopyrimidine combination]. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol (1966) 0.93
THE ADRENERGIC SYSTEM AND SYMPATHOMIMETIC AMINES. Adv Pharmacol (1964) 0.93
The effect of priscoline, papaverine, and nicotinic acid on blood flow in the lower extremity of man. Surgery (1950) 0.92
Reactivity of renal and systemic circulations to vasoconstrictor agents in normotensive and hypertensive subjects. J Clin Invest (1962) 0.90
[Progress in the field of plasmakinins]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1963) 0.90
On migraine headache: serotonin and serotonin antagonism. JAMA (1962) 0.89
[Effect of vaso-active substances on muscular and cutaneous circulation in man]. Z Kreislaufforsch (1954) 0.88
Appraisal of methysergide in treatment of vascular headaches of migraine type. JAMA (1963) 0.88
The cerebral peripheral circulatory action of nylidrin hydrochloride. Am J Med Sci (1960) 0.88
The effects of intravenous priscoline on cerebral circulation and metabolism. J Clin Invest (1953) 0.88
A study of the effect of vasopressin on portal and systemic blood pressure. Surg Gynecol Obstet (1962) 0.87
The effect of intravenous papaverine hydrochloride on the cerebral circulation. J Clin Invest (1952) 0.85
Hemodynamic effects of angiotensin, norepinephrine, and bradykinin continuously measured in unanesthetized dogs. Am J Physiol (1961) 0.85
The pharmacology of catecholamines and their derivatives. I. Relationship between structure and activity especially as far as the vascular system is concerned. Arzneimittelforschung (1963) 0.83
[The carcinoid syndrome with a report of metastasizing bronchial carcinoid]. Dtsch Med Wochenschr (1960) 0.83
The effect of nylidrin hydrochloride (arlidin) on the cerebral circulation. Am J Med Sci (1960) 0.83
A pharmacological comparison between synthetic bradykinin and synthetic kallidin. J Pharmacol Exp Ther (1963) 0.83
[On the suitability of nicotinic acid preparations in therapy of circulatory disorders in fingers and toes]. Klin Wochenschr (1952) 0.83
[Circulatory studies with synthetic hypertensin II]. Klin Wochenschr (1958) 0.83
GENERAL CIRCULATORY ALTERATIONS INDUCED BY INTRAVENOUS INFUSIONS OF SYNTHETIC BRADYKININ IN MAN. Circulation (1964) 0.83
Clinical trial of ilidar; a new dibenzazepine adrenergic blocking drug, in the treatment of peripheral vascular diseases and miscellaneous complaints. Circulation (1954) 0.82
Sustained dilatation in human muscle blood vessels under the influence of adrenaline. J Physiol (1962) 0.81
[PHYSIOLOGY AND PATHOPHYSIOLOGY OF CEREBROVASCULAR CIRCULATION]. Med Welt (1965) 0.80
[Bradykinin, Information on its structure, synthesis and physiologic-pharmacological bases]. Dtsch Med Wochenschr (1961) 0.79
[The effects of adenyl compounds on the blood circulation of the resting human skeleton muscle]. Klin Wochenschr (1955) 0.79
[Pharmacologic studies of new sympatol derivatives]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1951) 0.78
[Effect of 5-hydroxytryptamine on blood pressure, skin and muscle blood supply in humans]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1957) 0.78
The circulatory action of theophylline ethylene diamine. Clin Sci (Lond) (1947) 0.78
The sympathetic vasomotor innervation of the skin of the dog. Acta Physiol Scand (1949) 0.77
[Studies on the effectivness of orally dispensed 1- (3'-Hydroxyphenyl)-2-aminoethanol-hydrochlorid (Novadral)]. Med Welt (1966) 0.77
[Behavior of portal vein pressure of unanesthetized dogs under the effect of some vasoactive drugs]. Verh Dtsch Ges Kreislaufforsch (1956) 0.77
Circulatory and diuretic effects of theophylline isopropanolamine. Arch Intern Med (Chic) (1949) 0.76
[Vasodilative aralkyls of the adrenalin-benzedrine group. I. Effects on blood pressure]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1951) 0.76
A useful muscarinic parameter and the differential recording of atrial and ventricular tension in the perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmakol (1971) 2.74
A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents. Br J Pharmacol Chemother (1968) 2.20
A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmakol (1969) 2.07
[Differences between tyramine and dimethylphenylpiperazine in the Ca++-dependency and in the temporary course of noradrenaline release from the isolated rabbit heart]. Experientia (1967) 1.42
Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol (1980) 1.19
Modification of sympathetic function. Indirectly acting sympathomimetic amines. Pharmacol Rev (1966) 1.17
Autonomic nervous system: newer mechanisms of adrenergic blockade. Annu Rev Pharmacol (1966) 1.15
Inhibition by parasympathetic nerve stimulation of the release of the adrenergic transmitter. Naunyn Schmiedebergs Arch Pharmakol (1970) 1.15
Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Br J Pharmacol (1972) 1.14
Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol (1995) 1.08
Sympathetic Nerve Stimulation on the perfused rat heart. Affinities of N-methylatropine and pirenzepine at pre- and postsynaptic muscarine receptors. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.01
Arrhythmias and inhibition of noradrenaline uptake caused by tricyclic antidepressants and chlorpromazine on the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.01
Muscarinic inhibition of potassium-induced noradrenaline release and its dependence on the calcium concentration. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.98
The effect of physostigmine on the vagally induced muscarinic inhibition of noradrenaline release from the isolated perfused rabbit atria. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.96
The determination of presynaptic pA2 values of yohimbine and phentolamine on the perfused rat heart under conditions of negligible autoinhibition. Br J Pharmacol (1983) 0.96
The effects of several muscarinic antagonists on pre- and postsynaptic receptors in the isolated rabbit heart. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.95
[Inhibition of the uptake or alpha-methylnoradrenaline by the heart by sympathomimetic amines]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1965) 0.92
The effects of the tricyclic antidepressants desipramine, doxepin and iprindole on the isolated perfused rabbit heart. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.91
The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.91
[Functional importance of liberation of dihydroxyephedrine and dihydroxypseudoephedrine as "false" sympathetic transmitter substances in the heart]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.87
Nicotine receptors do not modulate the 3H-noradrenaline release from the isolated rat heart evoked by sympathetic nerve stimulation. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.87
Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.84
The effect of methacholine on noradrenaline release from the rabbit heart perfused with indometacin. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.84
[Demonstration of alpha-methylnoradrenaline in the urine of hypertensive patients treated with alpha-methyldopa]. Klin Wochenschr (1966) 0.83
Dopamine release and synthesis in the neurointermediate lobe of the rat hypophysis in vitro after electrical stimulation of the pituitary stalk. Brain Res (1983) 0.83
[Effect of d-amphetamine on the output of noradrenaline from isolated rabbit hearts]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.83
Cholinesterase activity and exposure time to acetylcholine as factors influencing the muscarinic inhibition of [3H]-noradrenaline overflow from guinea-pig isolated atria. Br J Pharmacol (1985) 0.83
A presynaptic excitatory M1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.82
Effect of sympathomimetic amines on the response of the perfused mesenteric artery preparation to adrenergic nerve stimulation. Arzneimittelforschung (1969) 0.81
Atropine-resistant effects of the muscarinic agonists McN-A-343 and AHR 602 on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Br J Pharmacol (1974) 0.81
Gadolinium ions inhibit exocytotic vasopressin release from the rat neurohypophysis. J Physiol (1985) 0.81
Modulation by fenoldopam (SKF 82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Effects of dopamine depletion. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.81
[Comparative study of the blood pressure effect, uptake and storage of dihydroxyephedrine (alpha-methyladrenaline) and dihydroxypseudoephedrine]. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol (1966) 0.81
Muscarinic inhibition of [3H]-noradrenaline release on rabbit iris in vitro: effects of stimulation conditions on intrinsic activity of methacholine and pilocarpine. Br J Pharmacol (1988) 0.81
[Increase of noradrenaline effects by tyramine]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1965) 0.80
Proceedings: The time course of noradrenaline release caused by high potassium-low sodium solution. Effects of methacholine or decrease of the calcium ion concentration. Br J Pharmacol (1975) 0.79
Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from the sympathetic nerves of the rabbit heart. Br J Pharmacol (1971) 0.79
Effects of rest and physical activity on the urinary excretion of noradrenaline and alpha-methylnoradrenaline in human subjects treated with alpha-methyldopa. Eur J Pharmacol (1968) 0.78
The effect of alpha-methyldopa on the vasoconstrictor responses of the rat mesenteric artery preparation to nerve stimulation. Arzneimittelforschung (1969) 0.78
Short- and long-latency muscarinic inhibition of noradrenaline release from rabbit atria induced by vagal stimulation. J Physiol (1988) 0.78
Autoinhibition of noradrenaline release from the rat heart as a function of the biophase concentration. Effects of exogenous alpha-adrenoceptor agonists, cocaine, and perfusion rate. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.77
Isoprenaline and forskolin increase evoked vasopressin release from rat pituitary. Eur J Pharmacol (1982) 0.77
The mechanism of neuronal noradrenaline and dopamine beta-hydroxylase release by a sodium-deficient solution substituted with urea. Neuroscience (1980) 0.77
Do adrenergic fibres have muscarinic inhibitory receptors?-- a reply. J Pharm Pharmacol (1974) 0.77
[Adrenergic alpha and beta receptors and their specific inhibitors]. Klin Wochenschr (1968) 0.76
Facilitation by 'low sodium-urea' medium of the washout of dopamine beta-hydroxylase released by potassium ions from the perfused rabbit heart. Neuroscience (1980) 0.76
Evidence that dopamine is a neurotransmitter in the neurointermediate lobe of the hypophysis. Prog Brain Res (1983) 0.76
[The effect of ouabain on the elimination of noradrenaline from the perfusion liquid of isolated rabbit heart]. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol (1966) 0.76
Structure-activity relationship of compounds which block receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart [proceedings]. Br J Pharmacol (1977) 0.75
[Liberation of alpha-methylnorepinephrine by sympathetic activity in humans following application of alpha-methyldopa]. Verh Dtsch Ges Inn Med (1968) 0.75
Noradrenaline depleting and blood pressure lowering activity of threo-corbadrine. Eur J Pharmacol (1968) 0.75
[Studies on noradrenaline liberation by acetylcholine in the perfused rabbit heart]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.75
Storage and release of false transmitters after infusion of (+)- and (-)- -methyldopamine. Naunyn Schmiedebergs Arch Pharmakol (1971) 0.75
Absence of muscarinic modulation of vasopressin release from the isolated rat neurophypophysis. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
[Effects of threo-corbadrine on the storage of amines and blood pressure of rats]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
[Role of adrenergic mechanisms in origin of arrhythmias following administration of tricyclic antidepressive agents]. Dtsch Med Wochenschr (1976) 0.75
[Uptake of threo-corbadrine and its liberation as false sympathetic transmitter substance]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Ultrastructural changes in atrial sympathetic nerves during perfusion with solutions deficient in sodium and compensated by potassium or urea [proceedings]. Br J Pharmacol (1977) 0.75
[Excretion of alpha-methylnoradrenaline in the urine of hypertensive patients during treatment with alpha-methyldopa]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.75
Muscarinic inhibition of the release of the adrenergic transmitter from peripheral sympathetic fibres. Acta Physiol Pol (1973) 0.75
[Vasoactive endogenous substances and pharmacological agents with peripheral action]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1967) 0.75
[Release of false transmitters after infusion of (+)- and (-)-alpha-methyldopamine]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.75
Refflux of exogenously administered noradrenaline from the adrenergic neurone and extraneuronal compartments. Acta Physiol Pol (1973) 0.75
[Ulf Svante von Euler]. Dtsch Med Wochenschr (1971) 0.75
[Excretion of catecholamines and amine metabolites of alpha-methyldopa in the urine at different time intervals after the last administered dose]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
The effects of methacholine and calcium deprivation on the release of the false transmitter, alpha-methyladrenaline, from the isolated rabbit heart. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.75
Kinetic analysis of stimulation-evoked overflow of noradrenaline and dopamine beta-hydroxylase from the isolated rabbit heart. The effect of DOPA decarboxylase inhibition. Neuroscience (1982) 0.75
[On the importance of the formation of metabolites for the blood pressure-lowering effect of alpha-methyldopa]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.75
[Mechanisms of sympathetic function inhibition and its importance in the treatment of hypertension]. Internist (Berl) (1966) 0.75
Impulse interval-dependent effect of sympathetic nerve stimulation on evoked acetylcholine release from the rabbit perfused atria preparation. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.75
[Pharmacological principles of the therapy using adrenergic receptor inhibitors]. Hippokrates (1970) 0.75
The interferance of muscarinic receptors with the noradrenaline release from sympathetic nerve endings caused by nicotinic agents. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
[Blockade of the postganglionic sympathetic nerve fiber mediated by nicotinic receptors]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.75
The role of cytoplasmic (newly synthesized) dopamine for the spontaneous and electrically evoked release of dopamine and its metabolites from the isolated neurointermediate lobe of the rat pituitary gland in vitro. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.75
Atrial sympathetic nerves after perfusion of the rabbit heart with low sodium solutions containing potassium chloride or urea--a biochemical, histochemical and fine structural study. Neuroscience (1978) 0.75
The use of the De Deckere-Ten Hoor preparation for study of nicotinic and potassium-evoked dopamine beta-hydroxylase release from the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.75
Uptake of [3H]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. Effects of desipramine and nomifensine. J Neurochem (1983) 0.75
Studies on the formation of alpha-methylnoradrenaline in hypertensive patients treated with alpha-methyldopa. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.75
Co-transmitter mediated facilitation by sympathetic nerve stimulation of evoked acetylcholine release from the rabbit perfused atria preparation. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.75
Release and metabolism of [3H]dopamine in the neurointermediate lobe of the rat pituitary gland. Neuroscience (1985) 0.75
Endogenous opioids inhibit the in vitro release of endogenous dopamine preferentially in the neural lobe of the rat neurointermediate lobe. Life Sci (1986) 0.75
Acute hypertension after monoamine-oxidase inhibitors and the ingestion of cheese. Ger Med Mon (1965) 0.75
[Inhibitory effect of acetylcholine on the release of noradrenaline from isolated rabbit hearts stimulated sympathetically]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.75